Interference of urinary albumin-to-creatinine ratio measurement by glycosuria: clinical implications when using SGLT-2 inhibitors

Kidney Int. 2023 Apr;103(4):787-790. doi: 10.1016/j.kint.2022.12.027. Epub 2023 Feb 2.

¹ Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
² Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK; Medical Research Council-Population Health Research Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
³ Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK; Medical Research Council-Population Health Research Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK. Electronic address: will.herrington@ndph.ox.ac.uk.

No abstract available

Keywords: glycosuria; interference; sodium glucose cotransporter-2 inhibitor; urine albumin-to-creatinine ratio.

Publication types